The agenda includes:
1 Prepare a position paper on the evaluation of the drug Yescarta (axicabtagene ciloleucel) under the drug program B.12.FM. "Treatment of patients with B-cell lymphoma (ICD-10: C82, C83, C85)" ASCT line.
2 Prepare a position paper on the evaluation of the drug Yescarta (axicabtagene ciloleucel) under the drug program B.12.FM. "Treatment of patients with B-cell lymphoma (ICD-10: C82, C83, C85)" non-ASCT line.
3 Prepare a position paper on the evaluation of the drug Adcetris (brentuximabum vedotinum) within the framework of the drug program "Treatment of patients with classical hodgkin's lymphoma (ICD-10: C81)".
4 Prepare an opinion on the continuation of coverage of medicines containing the active substance carvedilolum i...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
